![David Warshawsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von David Warshawsky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vuja De Sciences, Inc.
![]() Vuja De Sciences, Inc. Pharmaceuticals: MajorHealth Technology Vuja De Sciences, Inc. is engaged in biotechnology services. The company was founded by David Warshawsky, Rick Lampe, Robert E. Hurst and Raphael Nir and is headquartered in Hoboken, NJ. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
Gründer | - | - |
Karriereverlauf von David Warshawsky
Ehemalige bekannte Positionen von David Warshawsky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Avraham Pharmaceuticals Ltd.
![]() Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Vorstandsvorsitzender | 01.01.2010 | - |
Gründer | 01.01.2010 | - | |
Präsident | 28.07.2010 | - |
Statistik
International
Israel | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Executive Officer | 2 |
Founder | 2 |
President | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Avraham Pharmaceuticals Ltd.
![]() Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Health Technology |
Vuja De Sciences, Inc.
![]() Vuja De Sciences, Inc. Pharmaceuticals: MajorHealth Technology Vuja De Sciences, Inc. is engaged in biotechnology services. The company was founded by David Warshawsky, Rick Lampe, Robert E. Hurst and Raphael Nir and is headquartered in Hoboken, NJ. | Health Technology |
- Börse
- Insiders
- David Warshawsky
- Erfahrung